“As part of my plan to obtain total independence from China, we will phase in tariffs and import restrictions to bring back production of all essential medicines to the United States of America where they belong.”
Sources (click to view full provenance)
Propose an edit to this promise's details
Suggest a sourced correction to the promise text, topic, scope, significance, or dates. Changing the promise text requires a source. Your suggestion is reviewed before it changes the record.
Free — it takes a minute. New here? Create an account and complete the Contributor Agreement once.
Assessments
evidence-backed verdictsThese are sourced verdicts from fact-checkers or community evidence reviews — not opinions.
The promised tariff phase-in is formally underway: after a Section 232 investigation opened April 1, 2025, Trump signed an April 2, 2026 proclamation imposing a 100% tariff on patented pharmaceutical imports, phasing in beginning July 31, 2026, with a reduced 20% rate for companies with approved U.S. onshoring plans, and the White House cites roughly $400 billion in resulting U.S. pharmaceutical investment commitments. However, generic drugs - the bulk of essential medicines - are expressly excluded from the tariffs 'at this time,' duties had not yet begun collection as of July 3, 2026, and reshored production remains largely at the commitment stage. The tariff mechanism is partially delivered, but the promised return of production of all essential medicines has not occurred.
Your opinion on this assessment(clearly labeled opinion)
Sign in to vote.
Discussion
community opinionsComments are user opinions — not verdicts. They do not affect the official assessment.
Sign in to join the discussion.
Propose a correction
community accountabilitySee an error in the promise text, status, significance, or missing source? Submit a sourced correction — a reviewer will evaluate and apply it if accurate. Your submission must cite evidence; unsourced changes are not accepted.
Sign in or create an account to propose a correction.
Debate
sourced community argumentsThese are sourced community arguments — not StumpWatch assessments. Each cites a source and is community-contributed; it does not change the official status or rating above.
No arguments yet
Be the first to weigh in. Every argument cites a source and is reviewed before it publishes. Create an account to add one and help keep this promise honest.
Add a sourced argument
Cite a source for your point. Submissions are held for reviewer approval before they appear.
Sign in or create an account to add an argument.